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Introduction
The regulation of plasma osmotic pressure, the binding and 
transport of endogenous and exogenous compounds, and anti-
oxidant functions comprise a set of quite diverse functions.1 A 
single molecule is involved in all of these bio-functions: albumin. 
Most of the antioxidant properties of albumin can be attributed 
to its three-dimensional structure and it has previously shown 
that all these properties could be partially impaired by reactive 
oxygen species (ROS).1-5 Oxidative stress is believed to play a 
pathophysiological role in a variety of disease and it is readily 
conceivable that the ligand binding properties of albumin may 
be altered during the development of these pathologies. Albumin 
exists in both reduced and oxidized forms in systemic circulation. 
The reduced form of the human serum albumin (HSA) has been 
shown to be lower in patients with hepatic disorders, diabetes, 
and renal diseases.4-5
HSA (66.5 kDa), a single chain of 585 amino acids, is the 
most abundant plasma protein in plasma, typically present at high 
concentrations (~0.6 mM).5-7 Therefore, ROS and products of 
their reactions with other macromolecules occur physiologically 
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and pathophysiologically in the vicinity of albumin. It consists 
of three structurally homologous, largely helical (67%) domains 
I, II, and III. Each domain consists of two sub-domains, A and 
B. Like other mammalian albumins, HSA contains 17 disulfide 
bridges and free thiol (sulphydryl) group at Cys-34.5-7 It is clear 
from previous publications that HSA has a variety of metal-bind-
ing sites with different specificity.1,6 The binding properties of 
HSA depend on the three dimensional structure of the binding 
sites, which are distributed over the albumin molecule.1 Domain 
II in HSA is the preferred site for binding as fatty acids and   
alpha-lipoic acid (LA) share structural similarity to the medium 
chain fatty acid, octanoic acid7 and this mechanism is shown in 
Figure 1.
Although LA and other antioxidant supplements are widely 
used by the public and can prove beneficial in some patient 
groups, there remains a lack of detailed knowledge on its extra-
cellular protective effects under different specific physiologi-
cal circumstances. LA (1,2-dithiolane-3-pentanoic acid) is a 
sulfur-containing antioxidant with metal-chelating and antigly-
cation capabilities. Unlike many antioxidants which are active 
only in lipid or aqueous phase, LA is active in both lipid and www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  207
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aqueous phases. LA is part of a redox pair, being the oxidized 
partner of the reduced form dihydrolipoic acid (DHLA). Due 
to an asymmetric carbon having four different attached groups, 
LA exists as two enantiomers: the (R)-enantiomer and the 
(S)-enantiomer. Naturally-occurring LA is the (R)-form, but 
synthetic LA is a racemic mixture of (R)-form and (S)-form.8 
Although the (R)-enantiomer is more biologically active than 
the (S)-enantiomer, administration of LA actually results in 
greater formation of DHLA due to a synergistic effect which 
each enantiomer exerts on the reduction of the other.8,9 On the 
other hand, LA and DHLA have been reported to exhibit metal-
chelating properties and the use of LA to remove metal ions in 
vivo has been proposed previously.10,11 Structurally, the two thiol 
groups and the carboxyl group of the LA allow binding of various 
divalent metals.12,13 Such chelation by LA appears to be effec-
tive in slowing iron- or copper-mediated oxidation of lipids13 or 
increase in oxidative protein damage10,11,14,15 in various biological 
model systems (Fig. 1).
Most of the information concerning antioxidant or pro-oxidant 
effects of LA is available in current literature.8,9,12,14,15 However, 
information concerning the effectiveness of LA and DHLA to 
prevent in vitro metal-catalyzed protein oxidation (MCO) of 
HSA does not appear to be available of the relevant literature. 
The aims of the current study were to examine and compare the 
effectiveness of LA and DHLA to prevent to MCO of HSA, and 
to investigate this effect as a function of its concentration.
Results
The declining kinetics in the absorbtion of MCO buffer for 15 
minutes at 265 nm is seen in Figure 2. When HSA was added to 
the oxidation mixture, it was observed that it slowed down the 
MCO reaction mildly in this time interval and compared in the 
same figure.
Variations in the levels of protein oxidation markers are shown 
in Figures 3, 4 and 5, respectively. Evidently, oxidation of HSA 
is observed under these conditions; POOH, PCO and AOOP 
levels were increased when HSA was exposed to MCO without 
any antioxidant maintenance significantly. In the inspection of 
LA and DHLA effects due to their concentration in the reaction 
Figure 1. Metal ion-catalyzed albumin oxidation, alpha-lipoic acid, and intravascular redox homeostasis. ROs, reactive oxygen species; MCO, metal-
catalyzed protein oxidation; La, alpha-lipoic acid; DhLa, dihydrolipoic acid; pOOh, protein hydroperoxides; pCO, protein carbonyl groups; aOpp, 
advanced oxidation protein products.208  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 3
medium, decreasing PCO and POOH levels were observed when 
25 µM and 50 µM LA and DHLA were used independently   
(Figs. 3 and 4), but both PCO and POOH levels showed 
increase subsequently when 75 µM LA and DHLA were used. 
There was no significant difference when PCO and POOH lev-
els of 25 µM and 50 µM LA were compared (p > 0.05, p > 
0.05), so was when the levels of 25 µM and 50 µM DHLA 
were compared respectively (p > 0.05, p < 0.05). When 100 µM 
LA and DHLA applied, the increment seen in PCO an POOH 
levels was striking and even there was no significant difference 
when POOH levels of 100 µM LA group were compared with 
the group deprived of LA or DHLA (p>0,05). In Figure 5; 
AOPP levels are given which were quite amicable with PCO 
and POOH levels when both LA and DHLA were discussed. 
Along with 25 µM and 50 µM of LA and DHLA; AOPP levels 
declined consecutively but an elevation was seen when LA and 
DHLA concentrations rised to 75 µM and it was striking with 
100 µM concentration. Both 100 µM LA and DHLA adminis-
tration showed no significant difference when AOPP levels were 
compared with the group comprising no LA or DHLA (p > 0.05 
for both parameters). When each applied concentration of LA 
and DHLA were compared amongst; DHLA indicated statisti-
cally lower PCO levels with 25, 50 and 75 µM concentrations 
when compared with the same LA concentrations (p < 0.001, 
p < 0.001, p < 0.001) respectively. There was no significant 
difference when PCO levels of 100 µM DHLA and LA were 
compared (p > 0.05). With POOH levels; the only significant 
difference was seen when 25 µM DHLA and LA concentrations 
were compared (p < 0.001), DHLA caused lower POOH levels 
than that of LA. When AOPP levels were evaluated considering 
comparison within the same concentrations of LA and DHLA; 
50 µM and 100 µM applied DHLA showed lower AOPP for-
mation than same concentrations of LA (p < 0.001, p < 0.001) 
respectively.
The varations in the levels of P-SH groups are seen in Figure 
6. Both LA and DHLA administration showed increase with   
25 µM and 50 µM concentrations when compared with the 
absence of LA or DHLA. 75 µM LA and DHLA lowered the levels 
and the decrease was obvious with 100 µM LA and DHLA, even 
no significant difference was seen when compared with the absence 
of LA or DHLA (p > 0.05, p > 0.05) respectively. Statistically 25, 
50 and 75 µM of DHLA showed more effective on P-SH levels 
when compared within same concentrations of LA (p < 0.001,   
p < 0.001, p < 0.001). No significant difference was observed 
when 100 µM DHLA and LA were compared (p > 0.05).
Discussion
Proteins make up the majority of biomolecules in cells and 
plasma and therefore are the most likely reactants with ROS. 
Oxidative damage by free radicals in biological systems is often 
linked to the Fenton reaction. The Fenton reaction is the one 
electron reduction of hydrogen peroxide (H2O2) by the transition 
metal ions such as iron and copper. The Fenton reaction is also 
another way of producing free radicals in experimental settings. 
In vivo and in vitro, HSA may be oxidatively modified in dif-
ferent ways with different agents at different sites.1,6,7 The redox 
status of HSA can affect its binding properties in several ways, 
including altered conformation and consequently altered binding 
affinities at ligand-binding sites. On the other hand the ligand-
binding reaction itself is redox sensitive.1 The functional altera-
tion of oxidized HSA may have important clinical implications in 
critical conditions associated with high levels of oxidative stress.16 
Recent studies on HSA exposed to ROS have employed experi-
mental conditions that cause extensive molecular alterations like 
aggregation or fragmentation of the molecule.17,18
Oxidation of HSA was investigated by using different oxidant 
systems in vitro studies; the water-soluble azo-initiator 2,2’azo-
bis-(2-amidinopropane) hydrochloride (AAPH), a combina-
tion of FeCl3 and ascorbate or the Fenton oxidant consisting of 
FeCl2, H2O2 and EDTA,19 chloramine-T (a hypochloride ana-
logue),20 hypochlorus acid,21 and even malondialdehyde22 and 
Figure 2. The absorption spectra of in vitro metal catalyzed oxidation system at 265 nm (a) before and (B) following the albumin treatment.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  209
conformational and functional changes were investigated via 
MCO of HSA in different studies.19,23 MCO system is assumed to 
attack metal binding sites on proteins yielding site specific oxida-
tive modifications. In this study, we have investigated the action of 
a MCO system on HSA and the antioxidant/pro-oxidant effects 
of LA and DHLA due to function of their concentrations. The 
logical reasoning why we have chosen MCO of HSA is; besides 
the regulation of the plasma osmotic pressure, HSA binds and 
transports transition metal ions such as bile pigments, medium-
chain fatty acids LA and other lipophilic compounds7,24-26 and 
is a known target of in vivo MCO.27 The concentration of iron 
used in our MCO system similar with the plasma concentrations 
of these redox-active metal ions; Fe2+, Cu2+ and Zn2+ in vivo28 to 
confirm prediction based on in vitro models.
ROS scavenging by the cellular and plasma proteins result in 
the formation of reactive P-OOHs.29,40 P-OOHs are major inter-
mediates in radical-mediated protein oxidation reactions and form 
stable PCO groups.29,40 It is well established that the P-OOHs 
formed particularly on aliphatic amino acid residues (Val, Leu, 
Ile, Glu, Pro, Lys) are generated under the absolute requirement 
of the presence of oxygen. The P-OOHs may be reductively 
detoxified to hydroxides but their decomposition products can 
also result in the formation of further radicals that may propagate 
reaction chains. Catabolism of oxidised proteins including those 
containing hydroperoxides, would be expected to result in an 
increased extent of accumulation of modified proteins in plasma, 
with this potentially having deleterious consequences for cellular 
function.33,40 AOPP are the proteins, predominantly HSA and 
its aggregates damaged by oxidative stress.30 Albumin comprises 
the largest thiol pool in plasma. However, other thiol containing 
compounds with a low molecular weight exist. Albumin contains 
a total of 35 cysteine residues. Thirty-four of these are involved 
in intramolecular disulphide bonds while cysteine34 (cys34) 
remains free. In plasma, there exist several thiol/disulphide cou-
ples, including the Cys34 of albumin. In healthy adults, about 
70–80% of the Cys34 in albumin contains a free thiol group; 
25% of the Cys34 forms a disulphide with small thiol com-
pounds like another cysteine, homocysteine or glutathione.1 The 
extracellular redox potential of the cysteine/cystine redox couple 
was reported to be kept constant and important for regulation of 
Figure 3. (a) Variations of protein carbonyl groups (pCO) in albumin 
molecule exposed to metal catalyzed oxidation (MCO) with respect to 
incremental lipoic acid (La) concentrations. Results are expressed as 
mean ± s.e.M. pCO levels were expressed as nmol/mg protein. Data 
are statistically significant at *,†,ƒ,#p < 0.001. (B) Variations of protein 
carbonyl groups (pCO) in albumin molecule exposed to metal catalyzed 
oxidation (MCO) with respect to incremental dihydolipoic acid (DhLa) 
concentrations. Results are expressed as mean ± s.e.M. pCO levels 
were expressed as nmol/mg protein. Data are statistically significant at 
*,†,ƒ,#p < 0.001 and **p < 0.01 respectively.
Figure 4. (a) Variations of protein hydroperoxides (pOOh) in albumin 
molecule exposed to metal catalyzed oxidation (MCO) with respect to 
incremental lipoic acid (La) concentrations. Results are expressed as 
mean ± s.e.M. pOOh levels were expressed as nmol/mg protein. Data 
are statistically significant at *,†,ƒ,#p < 0.001 and **,§p < 0.01 respective-
ly. (B) Variations of protein hydroperoxides (pOOh) in albumin molecule 
exposed to metal catalyzed oxidation (MCO) with respect to incremen-
tal dihydrolipoic acid (DhLa) concentrations. Results are expressed as 
mean ± s.e.M. pOOh levels were expressed as nmol/mg protein. Data 
are statistically significant at *,†,ƒ,#p < 0.001 and ‡p < 0.01 respectively.210  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 3
intracellular functions.31 Oxidative processes of the proteins have 
been widely reviewed by Stadmand and Levine.29
The oxidation of HSA results in an increase in PCO content. 
Both the POOH, PCO, and AOPP contents increased signifi-
cantly with the time of incubation in our MCO assay system 
when compared with the levels in LA and DHLA applied sam-
ples. The current results showed a significant decrease in the level 
of free thiol groups when HSA was incubated in the absence of 
LA or DHLA. The antioxidant capacity of HSA against in vitro 
MCO in the absence of LA and DHLA is seen in Figure 2. When 
HSA was added to the oxidation mixture, it was observed that it 
slowed down the MCO reaction mildly in this time interval and 
compared in the same figure and the intersection point seen in 
the graph is probably where the reaction is ended and the anti-
oxidant capacity of HSA is depleted. These findings indicate that 
HSA is highly oxidized at redox-active Cys 34 residue. As the LA 
and DHLA concentrations were increased from 25 to 100 µM, 
we observed two important points. High levels of HSA oxidation 
seemed to be decreased with 25 and 50 µM concentrations grad-
ually while P-SH groups increased. On the other hand at 75 µM 
concentration of both LA and DHLA there was no additional 
improve on HSA oxidation and the MCO of HSA seemed to be 
increased as if there was no protection of these antioxidants with 
100 µM concentration. P-SH levels were amicable with these 
data. We can state that; 75 µM has been the critical concentra-
tion value discriminating the antioxidant/prooxidant effects of 
LA and DHLA and with 100 µM concentration the prooxidant 
effects of both LA and DHLA were seen. AOPP contain abun-
dantly dityrosines which allow crosslinking, disulfide bridges 
and carbonyl groups.30 According to our current results; PCO 
and AOPP oxidation patterns seem to be compatible in respect to 
response to LA application. These data correspond to the recent 
findings20,30 indicating AOPP formation could happen to be par-
tially from PCO reactions. According to our results, it was clearly 
seen that DHLA was more influential on MCO when compared 
with that of LA.
Suji et al.6 find that modification of bovine serum albumin by 
the physiological dicarbonyl compound methylglyoxal results in 
a new binding site for the ligand LA and probable reason for this 
altered binding characteristics seem to be conformational changes 
induced during LA binding. The relevant literature indicates that 
Figure 5. (a) Variations of advanced oxidation protein products (aOpp) 
in albumin molecule exposed to metal catalyzed oxidation (MCO) with 
respect to incremental lipoic acid (La) concentrations. Results are ex-
pressed as mean ± s.e.M. aOpp levels were expressed as nmol per liter 
of chloramin-T equivalent/mg protein. Data are statistically significant 
at *,†,ƒ,#p < 0.001. (B) Variations of advanced oxidation protein products 
(aOpp) in albumin molecule exposed to metal catalyzed oxidation 
(MCO) with respect to incremental dihydrolipoic acid (DhLa) con-
centrations. Results are expressed as mean ± s.e.M. aOpp levels were 
expressed as nmol per liter of chloramin-T equivalent/mg protein. Data 
are statistically significant at *,†,ƒ,#p < 0.001. 
Figure 6. (a) Variations of protein thiol (p-sh) groups in albumin 
molecule exposed to metal catalyzed oxidation (MCO) with respect to 
incremental lipoic acid (La) concentrations. Results are expressed as 
mean ± s.e.M. p-sh levels are expressed as nmol/mg protein. Data are 
statistically significant at *,†,ƒ,#p < 0.001 and §p < 0.01 respectively.  
(B) Variations of protein thiol (p-sh) groups in albumin molecule ex-
posed to metal catalyzed oxidation (MCO) with respect to incremental 
dihydrolipoic acid (DhLa) concentrations. Results are expressed as 
mean ± s.e.M. p-sh levels are expressed as nmol/mg protein. Data are 
statistically significant at *,†,ƒ,#p < 0.001 and §p < 0.01 respectively.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  211
antioxidant/pro-oxidant effect of LA/DHLA depends on its 
dose.8,15,32 For example, in tumor cells, LA at low concentrations 
(1 µmol/L) increased cell proliferation rate, while LA at high 
concentrations (100 µmol/L) exhibited a distinct anti-prolifera-
tive effect.33 In addition, LA could act as a prooxidant at particu-
lar concentrations in chemical systems and living tissues. 8,14,15 
The concentration range of LA and DHLA tested in our study is 
on the same level with the concentrations used in in vivo stud-
ies.34-37 In this respect our study partially clarifies for the in vivo 
redox status of HSA with LA and DHLA. Also, it can be said 
that thiol-based antioxidants may not only fail to alleviate ROS 
toxicity, but in certain circumstances, such as their redox status, 
concentration, and optically active form,8 even promote it.
Although redox homeostasis mechanisms are often studied in 
cellular systems, it is likely that the main benefits of redox-active 
agents such as LA and DHLA should be investigated by com-
promised systems where oxidative stress is intermittently high. 
In the present study, it was intended to form the model condi-
tions of MCO on HSA that imitating the physiological condi-
tions in vitro. We observed the probable effects of LA/DHLA 
redox couple on HSA oxidation depending on the concentra-
tion and redox status. We can say that uptake and recycling of 
antioxidants depends on the cell type or redox state of cellular/
extracellular environment, so with this experiment we could sta-
bilize the conditions. We also provide the first demonstration 
that the HSA oxidation in MCO system was evidenced not only 
with protein carbonylation but also with POOH, AOPP forma-
tion and loss of P-SH groups so this is the most new point of 
this study.
Considering LA being extensively investigated clinically and 
has been shown to be redox sensitive, it is capable of acting as a 
pro-oxidant and/or antioxidant in certain conditions. The oxi-
dized (LA) and reduced (DHLA) forms create a potent redox 
couple that has a standard reduction potential of −0.32 V. This 
makes DHLA one of the most potent naturally occurring anti-
oxidants.38 Iron is a redox active element, which can seriously 
exacerbate oxidative stres by generating OH radicals via Fenton 
chemistry. DHLA accelerated irondependent OH generation. 
Generation and lipid peroxidation, probably by reducing Fe+3 to 
Fe+2. LA inhibited this pro-oxidant action of DHLA. DHLA can 
also exert pro-oxidant properties, both by its iron ion-reducing 
ability (Fig. 1).15 In this study, LA, and especially DHLA, seem 
have the ability to prevent MCO and like LA, DHLA also che-
lates transition metal ions and in turn alleviates metal-catalyzed 
protein oxidation reactions in moderate doses. However, in high 
concentrations the converse effects of both exists. If LA exerts 
similar effects to those seen in the present study, it is possible 
that cellular prooxidant effect could result. 
Oxidative stress is believed to play a pathophysiological 
role in different diseases39 and contributes to the pathophysi-
ology of exposure to metals. It is readily conceivable that the 
ligand-binding properties of albumin may be altered during 
the development of these pathologies. Excessive levels of serum 
iron has been observed to be a risk factor for an increasing 
number and diversity of disease conditions.40 Age-related dis-
orders influence the redox state of albumin and this influences 
the ligand-binding properties. LA and its reduced form DHLA 
are both capable of acting as antioxidants (Fig. 1). However, 
antioxidant performance of HSA has not been entirely clari-
fied due to a lack of understanding of all these redox homeo-
stasis mechanisms in human plasma. In our opinion: Human 
studies are limited in this regard. The administration of vari-
ous natural or synthetic antioxidants has been shown to be of 
benefit in prevention and attenuation metal-induced oxidative 
alterations in human plasma. On the other hand, surprisingly, 
the antioxidant supplements may exhibit pro-oxidant proper-
ties and even worsen metal induced pro-oxidant damage.41
These findings will, we hope, lead to a new insight into 
the molecular pathogenesis of oxidized-HSA related human 
diseases such as atherosclerosis as oxidative stress is known 
to be a mediator.42 The mechanisms by which LA may con-
fer protection in models of established atherosclerosis were 
studied and it was found that LA reduced the proliferation of 
atherosclerotic plaques in the abdominal aorta and improved 
intravascular reactivity.43 In a previous study, a protective 
activity of alpha-lipoic acid in hypercholesterolemic-induced 
animals was investigated in atherosclerosis model. It was sug-
gested that LA posses a dual lipid lowering and anti-athero-
sclerotic properties indicated with low plasma triglyceride and 
low density lipoprotein levels and reduction of athero-lesion 
formation in hypercholesterolemic-induced rabbits.44 LA rep-
resents a potential agent on the vascular endothelium, record-
ing to LA/DHLA redox couple is one of the most powerful 
biological antioxidant systems.45 The favorable antioxidant, 
anti-inflammatory, metabolic and endothelial effects of LA 
shown in rodents recently published studies46 warrant further 
assessment of its potential role for prevention and treatment 
of cardiovascular diseases. On the other hand inhibition of 
MCO in systemic circulation by LA/DHLA redox couple may 
be one of the possible therapeutic effects of thiol-based anti-
oxidants, and thus the underlying molecular mechanism needs 
to be further clarifications.
Table 1. The rationale for oxidative stress assays and outlines the experiments performed
Abbreviation Parameters Assay characteristic
pCO (nmol/mg protein) protein carbonyl groups Stable end products of protein oxidation
pOOh (nmol/mg protein) protein hydroperoxide groups Early products of protein oxidation
aOpp (nmol per liter of chloramin-T equivalent/mg protein) advanced oxidation protein products Heterogenous products of protein oxidation
p-sh (nmol/mg protein) protein thiol groups Redox sensitive functional group
pCO, protein carbonyl groups; p-OOh, protein hydroperoxide groups;  aOpp, advanced oxidation protein products; p-sh,  protein thiol groups  212  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 3
were dissolved in 1100 µL of 6 M guanidine hydrochloride. After 
mixing of the washed protein solution, xylenol orange, and fer-
rous solutions, the absorbance at 560 nm was read after 60 min 
against a blank containing 6 M guanidine hydrochloride instead 
of the protein solution. The molar concentration of P-OOHs in 
the final medium was calculated with the Beer-Lambert equa-
tion by using the molar absorption coefficient value of 37,000 
M-1cm-1. The coefficients of intra- and inter-assay variations   
for P-OOH assay were determined as 3.2% (n = 10) and 7.9%   
(n = 10), respectively.
Assay of protein carbonyl groups. PCO groups react with 
2,4-dinitrophenylhydrazine (DNPH) to generate chromophoric 
dinitrophenylhydrazones. DNPH was dissolved in HCl, and after 
the DNPH reaction, proteins were precipitated with an equal vol-
ume of 20% (w/v) trichloroacetic acid and washed three times 
with 4 mL of an ethanol/ethyl acetate mixture (1:1). Washings 
were achieved by mechanical disruption of pellets in the washing 
solution using a small spatula, and re-pelleting by centrifugation 
at 6000 g for 5 min. Finally, the protein precipitates were dis-
solved in 6 M-guanidine-HCl solution and the absorbances were 
measured at 360 nm wavelength using the molar extinction coef-
ficient of DNPH, 2.2 x 104 M-1.cm-1.49
Assay of advanced protein oxidation products. Samples were 
prepared in the following way: 200 µL of sample was diluted 1:5 
in phosphate-buffered saline. 10 µL of 1.16 M potassium iodide 
was then added to each tube, two minutes later followed by the 
20 µL acetic acid. The absorbance of the reaction mixture was 
immediately read at 340 nm against a blank containing 2000 µL 
of phosphate buffered saline, 100 µL of KI, and 200 µL of acetic 
acid.50 The coefficients of intra- and inter-assay variations were 
determined as 1.5% (n=10) and 2.7% (n=10), respectively. 
Assay of protein thiol groups. P-SH groups was deter-
mined by using 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB).51   
The coefficients of intra- and inter-assay variations were 1.3% (n 
= 10) and 3.6% (n = 10), respectively.
Determination of protein concentrations. Since the conven-
tional methods such as Bradford’s method might not be suitable 
for determination of the oxidized protein concentration in the 
final solutions, protein determinations were checked by the UV 
absorption of proteins at 280 nm.
Statistical analysis. The level of statistical significance was 
determined by ANOVA with Tukey’s post-hoc test, using Instat 
statistical software. Results are expressed as mean ± SEM of at 
least three independent experiments.
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Methods
Materials. All reagents including recombinant HSA, racemic 
mixture of LA and DHLA were purchased from Sigma (St Louis, 
MO). Albumin isolated from blood serum or plasma is usually 
heterogeneous.6 The heterogeneity is caused by some of the fac-
tors such as the variable extent of oxidation of the thiol group 
at Cys-34 (e.g., as a disulfide) and variations in the number 
and types of bound fatty acids6 In the present work, we have 
attempted to avoid this problem by carrying out experiments 
with recombinant HSA. 
Metal catalyzed oxidation of recombinant human serum 
albumin. Recombinant HSA (100 mg) was dissolved at a con-
centration of 10 mg/mL in the oxidation buffer (50 mM HEPES, 
N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid buffer, pH 
7.4, containing 100 mM KCl and 10 mm MgCl2). The oxidation 
mixture was prepared by adding neutral ascorbic acid and FeCl3 
to final concentrations of 25 mM and 100 µM, respectively.47 To 
initiate reducing the Fe3+ to Fe2+, ascorbic acid was added to the 
oxidation buffer. Ascorbat oxidation was monitored for 15 min 
by measuring the loss of absorbance at 265 nm in a Beckman 
DU-640 spectrophotometer.12 To test antioxidant effect of LA 
(25, 50, 75, 100 µM) and DHLA (25, 50, 75, 100 µM) as a func-
tion of concentration, each of them was added separately in the 
same buffer. The oxidation mixture was incubated for 72 h at 
37oC in a shaking bath, after which oxidation procedure was ter-
minated by addition of EDTA (ethylenediaminetetraacetic acid) 
to 1 mM.47 Control samples were prepared in oxidation buffer 
supplemented with 1 mM EDTA.
Evaluation of protein oxidation extent. Assesment of of pro-
tein hydroperoxides (P-OOH) formation after LA/DHLA treat-
ment and susceptibility to protein carbonyl (PCO) formation 
were performed according to Kayali et al.48 and Reznick et al.49 
respectively. Advanced oxidation endproducts (AOPP) determi-
nation was carried out by the method of Witko-Sarsat.50 Protein 
thiol (P-SH) concentration was determined by using 5,5`-dithio-
bis(2-nitrobenzoic acid) (DTNB) as previously described by 
Hu.51 The rationale for oxidative stress assays and outlines the 
experiments performed were given in Table 1.
Assay of protein hydroperoxides. P-OOHs were measured 
by the guanidine-perchloric acid-ferric-xylenol orange method 
(G-PCA-FOX). 48 The assay is based on the oxidation of Fe2+ by 
peroxides in the presence of the dye xylenol orange that gives 
a coloured complex with the Fe3+ generated. The Fe-XO com-
plex can be measured in the visible absorbance range (560 nm). 
Proteins were precipitated from 100 µL of sample by the addition 
of 500 µL of 0.2 M ice-cold perchloric acid. Samples were kept on 
ice for 5 min and centrifuged at 6500 g. The precipitated proteins 
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